• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新型冠状病毒肺炎疫情期间消化系统恶性肿瘤的医学诊疗策略]

[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of COVID-19].

作者信息

Zhang Y, Xu J M

机构信息

Department of Gastrointestinal Oncology, the Fifth Medical Center, General Hospital of PLA, Beijing 100071, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):184-186. doi: 10.3760/cma.j.cn112152-20200227-00141.

DOI:10.3760/cma.j.cn112152-20200227-00141
PMID:32112549
Abstract

Since the outbreak of COVID-19 in December 2019, the diagnosis and treatment of patients with cancer have been facing great challenges. Although oncologists are not fighting on the front line to against the epidemic, during this special period, we should not only protect patients, their families and medical staff from the infection of novel coronavirus, but also minimize the impact of the epidemic on the diagnosis and the treatment of patients with cancer. Combining the guidelines for diagnosis and treatment of tumors with our clinical experience, in this epidemic period, we discuss the strategies for diagnosis, treatment, and follow-up of malignant tumors of the digestive system in this article.

摘要

自2019年12月新型冠状病毒肺炎疫情爆发以来,癌症患者的诊断和治疗面临着巨大挑战。虽然肿瘤学家没有奋战在抗击疫情的一线,但在这个特殊时期,我们不仅要保护患者、其家属和医护人员免受新型冠状病毒感染,还要尽量减少疫情对癌症患者诊断和治疗的影响。结合肿瘤诊疗指南和我们的临床经验,在这个疫情期间,我们在本文中探讨消化系统恶性肿瘤的诊断、治疗及随访策略。

相似文献

1
[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of COVID-19].[新型冠状病毒肺炎疫情期间消化系统恶性肿瘤的医学诊疗策略]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):184-186. doi: 10.3760/cma.j.cn112152-20200227-00141.
2
[Surgical treatment strategy for digestive system malignancies during the outbreak of COVID-19].[新型冠状病毒肺炎疫情期间消化系统恶性肿瘤的外科治疗策略]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):180-183. doi: 10.3760/cma.j.cn112152-20200223-00117.
3
[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of COVID-19].[新型冠状病毒肺炎疫情期间肝胆恶性肿瘤的诊疗探讨]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):187-191. doi: 10.3760/cma.j.cn112152-20200227-00137.
4
[Surgical treatment for esophageal cancer during the outbreak of COVID-19].[新型冠状病毒肺炎疫情期间食管癌的外科治疗]
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):296-300. doi: 10.3760/cma.j.cn112152-20200226-00128.
5
[Management strategy for the resumption of regular diagnosis and treatment in gastrointestinal surgery department during the outbreak of coronavirus disease 2019 (COVID-19)].[2019冠状病毒病(COVID-19)疫情期间胃肠外科恢复常规诊疗的管理策略]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Apr 25;23(4):321-326. doi: 10.3760/cma.j.issn.1671-0274.2020-0316-00146.
6
[Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].[2019新型冠状病毒病(COVID-19)疫情期间肺癌患者的诊断与治疗策略]
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):292-295. doi: 10.3760/cma.j.cn112152-20200229-00152.
7
Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil.巴西应对新冠疫情的非药物干预措施。
Epidemiol Serv Saude. 2020 Apr 9;29(2):e2020222. doi: 10.5123/S1679-49742020000200009.
8
Communication, collaboration and cooperation can stop the 2019 coronavirus.沟通、协作与合作可以阻止 2019 冠状病毒传播。
Nat Med. 2020 Feb;26(2):151. doi: 10.1038/s41591-020-0775-x.
9
Protecting healthcare workers from SARS-CoV-2 and other infections.保护医护人员免受 SARS-CoV-2 及其他感染。
Epidemiol Infect. 2020 Sep 21;148:e217. doi: 10.1017/S0950268820002198.
10
[Disinfection guideline of public transport during COVID-19 outbreak].[新冠疫情期间公共交通消毒指南]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Apr 6;54(4):344-346. doi: 10.3760/cma.j.cn112150-20200217-00129.

引用本文的文献

1
Endoscopy infection control strategy during the COVID-19 pandemic: experience from a tertiary cancer center in Brazil.COVID-19 大流行期间的内镜感染控制策略:巴西一家三级癌症中心的经验。
Clinics (Sao Paulo). 2021 Mar 8;76:e2280. doi: 10.6061/clinics/2021/e2280. eCollection 2021.
2
Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations.新冠疫情时代的上消化道肿瘤管理:感染风险、内镜作用的适应性转变以及潜在的治疗方案改变。
J Gastrointest Cancer. 2021 Jun;52(2):407-413. doi: 10.1007/s12029-020-00557-y. Epub 2020 Nov 26.
3
[Strategy for the practice of digestive and oncologic surgery in COVID-19 epidemic situation].
[新型冠状病毒肺炎疫情下消化与肿瘤外科手术实践策略]
J Chir Visc. 2020 Jun;157(3):S6-S12. doi: 10.1016/j.jchirv.2020.03.007. Epub 2020 Mar 31.
4
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency.清醒乳腺癌手术:COVID-19 紧急情况下的策略。
Breast Cancer. 2021 Jan;28(1):137-144. doi: 10.1007/s12282-020-01137-5. Epub 2020 Jul 30.
5
Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients.新冠疫情初期的 Tor Vergata 大学医院:为乳腺癌患者提供的经验与建议。
In Vivo. 2020 Jun;34(3 Suppl):1661-1665. doi: 10.21873/invivo.11958.
6
Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process.乳腺癌与 COVID-19:恐惧对患者决策过程的影响。
In Vivo. 2020 Jun;34(3 Suppl):1651-1659. doi: 10.21873/invivo.11957.
7
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).2019冠状病毒病疫情:消化系统癌症管理的建议替代方案:法国多组织临床观点(法国国立胃肠病学和消化肿瘤学会、法国癌症研究与治疗协会、胃肠癌研究组、法国国家癌症中心联盟、法国消化道癌症学会、法国消化内镜学会、法国肿瘤放射学会、法国放射学会)
Dig Liver Dis. 2020 Jun;52(6):597-603. doi: 10.1016/j.dld.2020.03.031. Epub 2020 May 14.
8
When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.当癌症遭遇新冠疫情在中国:我们遭受了什么、经历了什么、学到了什么。
Jpn J Clin Oncol. 2020 Jun 10;50(6):712-717. doi: 10.1093/jjco/hyaa077.
9
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.癌症患者和 COVID-19 大流行期间的研究:当前证据的系统评价。
Crit Rev Oncol Hematol. 2020 Jun;150:102972. doi: 10.1016/j.critrevonc.2020.102972. Epub 2020 Apr 22.
10
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.抗 COVID-19 冠状病毒(SARS-CoV-2)药物研发的最新进展和挑战——现状更新。
Infect Genet Evol. 2020 Sep;83:104327. doi: 10.1016/j.meegid.2020.104327. Epub 2020 Apr 19.